AEVI GENOMIC Cash Flow - Quarterly (NASDAQ:GNMX)

Add to My Stocks
$2.03 $0.06 (3.05%) GNMX stock closing price Mar 20, 2018 (Closing)

The cash flow statement is one of the reports a publicly traded company like AEVI GENOMIC needs to disclose. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about AEVI GENOMIC profits and AEVI GENOMIC debt. AEVI GENOMIC saw a cash impact of $- from the buyback of GNMX shares. The cash flow statement helps in the AEVI GENOMIC stock analysis by providing more information for evaluating changes in assets, liabilities and equities. AEVI GENOMIC saw a outflow of $- from investing activities till 2017 Q3.

View and download details of AEVI GENOMIC cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow---------
Net Increase (Decrease) in Assets Liabilities-0.12M-1.4M-0.77M2.09M1.73M-0.47M-0.42M-0.1M5.54M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net2.68M1.77M1M6.78M6.18M4.26M2.4M13.5M8.92M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment----0.22M-0.26M-0.19M-0.06M-0.18M-0.11M
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments---------
Other Cash Inflow (Outflow) from Investment Activities---------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares---19.74M19.72M19.75M-44.31M1.42M
Issuance (Repayment) of Debt Securities---------
Increase (Decrease) in Bank & Other Borrowings---------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities-0.14M--------
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year53.06M33.28M22.39M6.43M4.99M2.85M---
Cash & Equivalents at Year End14.96M21.35M29.2M39.83M47.25M53.68M43.89M53.06M17.72M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Teligent financial analysis

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The AEVI GENOMIC stock price history and AEVI GENOMIC stock comparison chart inevitably reflect its cash flow situation.

  • AEVI GENOMIC had a Net Change in Cash and Cash Equivalents of $-24.87M in the latest quarter 2017 Q3. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the AEVI GENOMIC stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. AEVI GENOMIC lost $-24.9M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: AEVI GENOMIC used $- cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $-0.12M for AEVI GENOMIC.

Key Financial Ratios For AEVI GENOMIC Cash Flow